news
Diabetic research suggests purslane herb extract mimics insulin
A new study has confirmed the anti-diabetic properties of the purslane herb extract Portulaca oleracea L.
List view / Grid view
Diabetes
news
New drug could prevent graft loss in pancreatic islet transplantation
5 December 2016 | By Niamh Louise Marriott, Digital Editor
In a rodent model of islet transplantation, ARA 290 markedly reduced transplantation-induced inflammation, resulting in a marked increase in islet survival...
news
Genetic differences in amino acid metabolism linked to high risk of diabetes
30 November 2016 | By Niamh Louise Marriott, Digital Content Producer
A study has identified the 5 genetic variants associated with higher levels of the branched-chain amino acids were associated with an increased risk...
article
How to be a research scientist: A conversation with Novo Nordisk’s Rahul Kapur
23 November 2016 | By Rahul Kapur, Head of Medical Affairs, Novo Nordisk UK and Ireland
We caught up with Novo Nordisk’s Rahul Kapur, to find out what it’s like to be at the forefront of diabetes research and what it takes to get there...
article
D is for Diabetes
17 November 2016 | By Niamh Louise Marriott, Digital Content Producer
D is for Diabetes - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest news and research into Diabetes...
news
3D printed customised insoles for diabetes patients
14 November 2016 | By Niamh Louise Marriott, Digital Content Producer
In the past, insoles for patients with diabetes were hand-made by orthopaedic shoemakers. In the future, these specialist shoemakers will be able to produce insoles more cost-effectively thanks to new software and the use of 3D printers. This approach means the mechanical properties of each insole can be assessed scientifically…
news
Diabetes opens floodgates to fructose
14 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The surprise is that diabetic mice absorb more fructose within minutes after it hits the stomach, sending it to the liver where it manufactures fat...
news
IDF calls for internationally standardised monitoring of cardiovascular disease in diabetics
29 September 2016 | By Niamh Louise Marriott, Digital Content Producer
It is difficult to estimate the global burden of cardiovascular disease in people with diabetes, due to lack of data and standardisation...
article
Vigilin: Could this drug target prevent a heart attack?
27 September 2016 | By ETH Zürich
Scientists identified a protein in liver cells, known as vigilin, which regulates the release of fats from the liver into the bloodstream. Find out more...
news
‘Library’ of de-prioritised pharma compounds available for researchers
UK scientists can apply for MRC funding to use any of the compounds in medical research studies to investigate the underlying mechanics of disease...
news
JDRF gives $2.5 million for T1D diabetes research agreement with Sernova
8 September 2016 | By Niamh Louise Marriott, Digital Content Producer
A new research funding agreement aims to address people with severe type 1 diabetes (T1D) who are hypoglycemia unaware, a condition in which a person with...
article
Could Pokémon Go help curb the diabetes pandemic?
15 August 2016 | By Niamh Louise Marriott, Digital Content Producer
Drug Target Review caught up with Dr Emily Burns, Research Communications Manager Diabetes UK to find out how this smartphone craze could impact the rising levels of Diabetes…
news
Metformin reduces toxic acid levels associated with MSUD
6 July 2016 | By Victoria White, Digital Content Producer
The widely-used diabetes drug, metformin, reduced the toxic acid levels associated with MSUD in both skin cells derived from MSUD patients and in mice...
article
The next revolution in stratified medicine: molecular phenotyping with metabolomics
The study of biochemistry provides molecular insights into how the human population ages, how diseases commence and progress, how molecular changes relate to disease remission and relapse, and how humans respond to treatments...
news
CV drug Darapladib shows potential in diabetic macular oedema
14 June 2016 | By Victoria White, Digital Content Producer
The discovery demonstrates that Darapladib has potential to provide protection against vision loss in a much wider group of patients with diabetes...
